Antenatal magnesium sulfate to prevent cerebral palsy. Issue 2 (7th July 2021)

• Record Type: Journal Article
• Authors: Keir, Amy K; Shepherd, Emily; McIntyre, Sarah; Rumbold, Alice; Groves, Charlotte; Crowther, Caroline; Callander, Emily Joy
• Is Part Of: Archives of disease in childhood. Volume 107:Issue 2(2022)
• Page Start: 225
• Page End: 227
• Publication Date: 2021-07-07
• Subjects: health services research -- neonatology; Infants -- Diseases -- Periodicals; Newborn infants -- Diseases -- Periodicals; Fetus -- Diseases -- Periodicals; 618.920105
• DOI: 10.1136/archdischild-2021-321817
• Languages: English
• ISSNs: 1359-2998

Abstract

Abstract : Magnesium sulfate given to women before birth at <30 weeks' gestation reduces the risk of cerebral palsy in their children. Our study aimed to assess the impact of a local quality improvement programme, primarily using plan-do-study-act cycles, to increase the use of antenatal magnesium sulfate. After implementing our quality improvement programme, an average of 86% of babies delivered at <30 weeks' gestation were exposed to antenatal magnesium sulfate compared with a historical baseline rate of 63%. Our study strengthens the case for embedding quality improvement programmes in maternal perinatal care to reduce the impact of cerebral palsy on families and society. Abstract : Embedding a quality improvement program on prenatal magnesium administration is feasible to reduce the impact of cerebral palsy.